Efficacy of Leflunomide on Joint Inflammation and Destruction of Joint Integrity in Active Rheumatoid Arthritis (RA) Patients.
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2011
At a glance
- Drugs Leflunomide (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Sanofi
- 07 Jun 2017 Biomarkers information updated
- 09 Feb 2006 New trial record.